MICHELLE PIEPER: Open Payments
NPI 1619986700 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 21 payments from 7 companies in 2025. Trend: 2023 $558 · 2024 $520 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $141 |
| Corcept Therapeutics | 3 | $95 |
| Astellas Pharma US Inc | 2 | $63 |
| Amgen Inc. | 3 | $55 |
| PFIZER INC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $24 |
Products named: Ozempic, Korlym, Veozah, EVENITY, JARDIANCE, PAXLOVID, UBRELVY, ELIQUIS.
Industry payments across NE — which companies pay providers there.
